Molecular epidemiology of HIV type 1 CRF02-AG in Cameroon and African patients living in Italy

AIDS Research and Human Retroviruses

Volumn 27, Issue 11, 2011, Pages 1173-1182

  Véras, Nazle Mendonca Collaço ^a,b   Santoro, Maria Mercedes ^c   Gray, Rebecca R ^a,d   Tatem, Andrew J ^d   Presti, Alessandra Lo ^e   Olearo, Flaminia ^f   Cappelli, Giulia ^g   Colizzi, Vittorio ^c,h   Takou, Desiré ^h   Torimiro, Judith ^h   Russo, Gianluca ⁱ   Callegaro, Annapaola ^j   Salpini, Romina ^c   D'Arrigo, Roberta ^k   Perno, Carlo Federico ^c,k   Goodenow, Maureen M ^a   Ciccozzi, Massimo ^e   Salemi, Marco ^a,d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF FLORIDA   (United States)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^g CNR   (Italy)

^h Centre International de Recherche Chantal Biya   (Cameroon)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j OSPEDALI RIUNITI   (Italy)

^k NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; ARTICLE; CAMEROON; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ITALY; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; PHYLOGEOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS STRAIN;

BAYES THEOREM; CAMEROON; EPIDEMICS; GENETICS, POPULATION; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; ITALY; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

EID: 80655128331     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0333     Document Type: Article

References (56)

1. HIV Sequence Database: http://www.hiv.lanl.gov/content/sequence/HIV/ mainpage.html.
2. AIDS epidemic update: Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009. http://www.unaids.org/en/default.asp.
3. Nkengasong JN, Janssens W, Heyndrickx L, et al.: Genotypic subtypes of HIV-1 in Cameroon. AIDS 1994;8:1405-1412. (Pubitemid 24296797)
4. Mauclère P, Loussert-Ajaka I, Damond F, et al.: Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS 1997;11:445-453. (Pubitemid 27113005)
5. Simon F, Mauclere P, Roques P, et al.: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998;4:1032-1037. (Pubitemid 28417335)
6. Takehisa J, Zekeng L, Ido E, et al.: Human immunodeficiency virus type 1 intergroup (M/O) recombination in Cameroon. J Virol 1999;73:6810-6820. (Pubitemid 29327864)
7. Triques K, Bourgeois A, Vidal N, et al.: Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K. AIDS Res Hum Retroviruses 2000; 16:139-151. (Pubitemid 30060984)
8. Carr JK, Torimiro JN, Nathan DW, Mpoudi NE, et al.: Novel HIV-1 forms are common in Cameroon. Virology 2001; 286:168-181.
9. Carr JK, Wolfe ND, Torimiro JN, et al.: HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: Evolutionary relics? Retrovirology 2010;28:7-39.
10. Konings FA, Haman GR, Xue Y, et al.: Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms. J Acquir Immune Defic Syndr 2006;42: 331-341. (Pubitemid 44050012)
11. Powell RL, Zhao J, Konings, FA, et al.: Circulating re-combinant form (CRF) 37-cpx: An old strain in Cameroon composed of diverse, genetically distant lineages of subtypes A and G. AIDS Res Hum Retroviruses 2007;23: 923-933.
12. Powell RL, Zhao J, Konings FA, et al.: Identification of a novel circulating recombinant form (CRF) 36-cpx in Cameroon that combines two CRFs (01-AE and 02-AG) with ancestral lineages of subtypes A and G. AIDS Res Hum Retroviruses 2007;23:1008-1019.
13. Brennan CA, Bodelle P, Coffey R, et al.: The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr 2008;49:432-439.
14. Ndembi N, Abraha A, Pilch H, et al.: Molecular characterization of HIV-1 and HIV-2 in Yaoundé, Cameroon: Evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol 2008;46:177-184.
15. Torimiro JN, D'Arrigo R, Takou D, et al.: Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon. New Microbiol 2009;32:325-332.
16. Yamaguchi J, Ndembi N, Ngansop C, et al.: HIV type 1 group M subtype G in Cameroon: Five genome sequences. AIDS Res Hum Retroviruses 2009;25:469-473.
17. Vallari A, Bodelle P, Ngansop C, et al.: Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low. AIDS Res Hum Retroviruses 2010;26:109-115.
18. Garcia-Calleja JM, Zekeng L, Louis JP, et al.: HIV infection in Cameroon: 30 months' surveillance in Yaounde. AIDS 1992; 6:881-882.
19. Peeters M: Recombinant HIV sequences: Their role in the global epidemic. In: HIV Sequence Compendium 2000 (Kuiken CL, et al., eds.). Theoretical Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2000, pp. I-39-54.
20. Fischetti L, Opare-Sem O, Candotti D, Lee H, and Allain JP: Higher viral load may explain the dominance of CRF02-AG in the molecular epidemiology of HIV in Ghana. AIDS 2004; 18:1208-1210.
21. Fischetti L, Opare-Sem O, Candotti D, Sarkodie F, Lee H, and Allain JP: Molecular epidemiology of HIV in Ghana: Dominance of CRF02-AG. J Med Virol 2004;73:158-166. (Pubitemid 38542667)
22. Sarr AD, Eisen G, Gueye-Ndiaye A, et al.: Viral dynamics of primary HIV-1 infection in Senegal, West Africa. J Infect Dis 2005;191:1460-1467. (Pubitemid 40563357)
23. Njai HF, Gali Y, Vanham G, et al.: The predominance of human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02 (CRF02-AG) in West Central Africa may be related to its replicative fitness. Retrovirology 2006; 3:1-11.
24. Ortiz M, Munoz L, Bernal A, et al.: Molecular characterization of non-B HIV type 1 subtypes from Africa in Spain. AIDS Res Hum Retroviruses 2000;16:1967-1971. (Pubitemid 32048454)
25. Parreira R, Pádua E, Piedade J, Venenno T, Paixao MT, and Esteves A: Genetic analysis of human immunodeficiency virus type 1 nef in Portugal: Subtyping, identification of mosaic genes, and amino acid sequence variability. J Med Virol 2005;77:8-16. (Pubitemid 41076470)
26. Falkensammer B, Doerler M, Kessler HH, et al.: Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria. Wien Klin Wochenschr 2007;119:181-185. (Pubitemid 46972229)
27. Thomson MM, Delgado E, Herrero I, et al.: Diversity of mosaic structures and common ancestry of human immunodeficiency virus type 1 BF intersubtype recombinant viruses from Argentina revealed by analysis of near full-length genome sequences. J Gen Virol 2002;83:107-119. (Pubitemid 34030815)
28. Monno L, Brindicci G, Lo Caputo S, et al.: HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-in-fected patients residing in two regions of central and southern Italy. J Med Virol. 2005;75:483-490. (Pubitemid 40293514)
29. Tramuto F, Bonura F, Perna AM, et al.: Group for HIV-1 Antiretroviral Studies in Sicily. Genetic diversity of HIV-1 non-B strains in Sicily: Evidence of intersubtype recombi-nants by sequence analysis of gag, pol, and env genes. AIDS Res Hum Retroviruses 2007;23:1131-1138. (Pubitemid 47571932)
30. MM Santoro, C Alteri, L Ronga, et al.: Evaluation of HIV-1 non-B subtypes in Italian treated patients from central Italy over the years 2001-2008. 7th European HIV Drug Resistance workshop, Stockholm, Sweden, 25-27 March 2009. Abstract 130.
31. Bracciale L, Colafigli M, Zazzi M, et al.: Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: Evolution over 12 years and predictors. J Anti-microb Chemother 2009;64:607-615.
32. Torti C, Lapadula G, Izzo I, et al.: Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: Public health implications. Epidemiol Infect 2010;29:1-10.
33. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global and regional distribution of HIV-1 genetic subtypes and recom-binants in 2004. AIDS 2006;20:W13-23. (Pubitemid 44611051)
34. Felsenstein J: Accuracy of coalescent likelihood estimates: Do we need more sites, more sequences, or more loci? Mol Biol Evol 2006;23:691-700. (Pubitemid 43278281)
35. Ceccherini-Silberstein F, Erba F, Gago F, et al.: Identification of the minimal conserved structure of HIV-1 protease in the presence or absence of drug pressure. AIDS 2004;18:11-19. (Pubitemid 39095777)
36. Giuliani M, Montieri S, Palamara G, et al.: Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy. AIDS Res Hum Retroviruses 2009;25:157-164.
37. Thompson JD, Higgins DG, and Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680. (Pubitemid 24354800)
38. Guindon S and Gascuel O: A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003;52:696-704. (Pubitemid 37365050)
39. Swofford DL and Sullivan J: Phylogeny inference based on parsimony and other methods using PAUP*. In: The Phylo-genetic Handbook: A Practical Approach to Phylogenetic Analysis and Hypothesis Testing, 2nd ed. (Lemey P, Salemi M, and Vandamme AM, eds.). Cambridge University Press, New York, 2009, pp. 267-312.
40. Anisimova M and Gascuel O: Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst Biol 2006;55:539-552. (Pubitemid 43922340)
41. Drummond AJ and Rambaut A: BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 2007;7:1-8.
42. Lemey P, Pybus OG, Rambaut A, et al.: The molecular population genetics of HIV-1 group O. Genetics 2004;167: 1059-1068. (Pubitemid 39045617)
43. Worobey M, Gemmel M, Teuwen DE, et al.: Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008;455:661-665.
44. Suchard MA, Weiss RE, and Sinsheimer JS: Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol 2001;18:1001-1013. (Pubitemid 32520473)
45. Slatkin M: Detecting small amounts of gene flow from phylogenies of alleles. Genetics 1989;121:609-612. (Pubitemid 19077113)
46. Salemi M, Lamers SL, Yu S, de Oliveira T, Fitch WM, and McGrath MS: Phylodynamic analysis of human immunodeficiency virus type 1 in distinct brain compartments provides a model for the neuropathogenesis of AIDS. J Virol 2005;79:11343-11352. (Pubitemid 41170676)
47. Maddison DR and Maddison WP: MacClade. In: Book Mac-Clade, 4.08 ed. Sinauer Associates, Inc., Sunderland, MA, 2008.
48. Nelson A: Estimated travel time to the nearest city of 500,000 or more people in year 2000. Vol. http://gem.jrc.ec.eur-opa.eu (accessed 17/02/2009) (Global Environment Monitoring Unit-Joint Research Centre of the European Commission, Ispra, Italy, 2008).
49. Gray RR, Tatem AJ, Lamers S, et al.: Spatial phylodynamics of HIV-1 epidemic emergence in east Africa. AIDS 2009; 23:F9-F17.
50. Ndongmo CB, Pieniazek D, Holberg-Petersen M, et al.: HIV genetic diversity in Cameroon: Possible public health importance. AIDS Res Hum Retroviruses 2006;22:812-816. (Pubitemid 44735010)
51. Thomson MM and Najera R: Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into western countries. Clin Infect Dis 2001; 32:1732-1737. (Pubitemid 32532004)
52. Kantor R: Impact of HIV-1 pol diversity on drug resistance and its clinical implications. Curr Opin Infect Dis 2006; 19:594-606. (Pubitemid 44665467)
53. Buonaguro L, Tornesello ML, and Buonaguro FM: Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: Pathogenetic and therapeutic implications. J Virol 2007;81:10209-10219. (Pubitemid 47463296)
54. Taylor BS, Taylor BS, Sobieszczyk ME, McCutchan FE, and Hammer SM: The challenge of HIV-1 subtype diversity. N Engl J Med 2008;358:1590-1602.
55. Easterbrook PJ, Smith M, Mullen J, et al.: Impact of HIV-1 viral subtype on disease progression and response to anti-retroviral therapy. J Int AIDS Soc 2010;13:2-9.
56. Peeters M, Toure-Kane C, and Nkengasong, JN: Genetic diversity of HIV in Africa: Impact on diagnosis, treatment, vaccine development and trials. AIDS 2003;17: 2547-2560 (Pubitemid 38402333)